Novartis Investigative Site

Alpharetta, Georgia 30022

0 studies enrolling now · 2 studies all time

What they study most

Moderate to Severe Chronic Plaque-type Psoriasis, Plaque Psoriasis

Studies at this site

• Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis — Completed
• Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis — Completed